293 related articles for article (PubMed ID: 27988109)
21. ETV6 fusion genes in hematological malignancies: a review.
De Braekeleer E; Douet-Guilbert N; Morel F; Le Bris MJ; Basinko A; De Braekeleer M
Leuk Res; 2012 Aug; 36(8):945-61. PubMed ID: 22578774
[TBL] [Abstract][Full Text] [Related]
22. Evolutionary divergence of platelet-derived growth factor alpha receptor signaling mechanisms.
Hamilton TG; Klinghoffer RA; Corrin PD; Soriano P
Mol Cell Biol; 2003 Jun; 23(11):4013-25. PubMed ID: 12748302
[TBL] [Abstract][Full Text] [Related]
23. BCR: a promiscuous fusion partner in hematopoietic disorders.
Peiris MN; Li F; Donoghue DJ
Oncotarget; 2019 Apr; 10(28):2738-2754. PubMed ID: 31105873
[TBL] [Abstract][Full Text] [Related]
24. P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer.
Katayama R; Sakashita T; Yanagitani N; Ninomiya H; Horiike A; Friboulet L; Gainor JF; Motoi N; Dobashi A; Sakata S; Tambo Y; Kitazono S; Sato S; Koike S; John Iafrate A; Mino-Kenudson M; Ishikawa Y; Shaw AT; Engelman JA; Takeuchi K; Nishio M; Fujita N
EBioMedicine; 2016 Jan; 3():54-66. PubMed ID: 26870817
[TBL] [Abstract][Full Text] [Related]
25. Profiling Receptor Tyrosine Kinase Fusions in Chinese Breast Cancers.
Tao Z; Liu J; Li T; Xu H; Chen K; Zhang J; Zhou H; Sun J; Han J; Guo Z; Yang H; Cao WM; Hu X
Front Oncol; 2021; 11():741142. PubMed ID: 34650924
[TBL] [Abstract][Full Text] [Related]
26. A novel protein tyrosine kinase NOK that shares homology with platelet- derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice.
Liu L; Yu XZ; Li TS; Song LX; Chen PL; Suo TL; Li YH; Wang SD; Chen Y; Ren YM; Zhang SP; Chang ZJ; Fu XY
Cancer Res; 2004 May; 64(10):3491-9. PubMed ID: 15150103
[TBL] [Abstract][Full Text] [Related]
27. Fibroblast growth factor receptor and platelet-derived growth factor receptor abnormalities in eosinophilic myeloproliferative disorders.
Cross NC; Reiter A
Acta Haematol; 2008; 119(4):199-206. PubMed ID: 18566537
[TBL] [Abstract][Full Text] [Related]
28. Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy.
Abou-Fayçal C; Hatat AS; Gazzeri S; Eymin B
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208660
[TBL] [Abstract][Full Text] [Related]
29. Functional characterization of a novel FGFR1OP-RET rearrangement in hematopoietic malignancies.
Bossi D; Carlomagno F; Pallavicini I; Pruneri G; Trubia M; Raviele PR; Marinelli A; Anaganti S; Cox MC; Viale G; Santoro M; Di Fiore PP; Minucci S
Mol Oncol; 2014 Mar; 8(2):221-31. PubMed ID: 24315414
[TBL] [Abstract][Full Text] [Related]
30. Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers.
Cheong TC; Jang A; Wang Q; Leonardi GC; Ricciuti B; Alessi JV; Di Federico A; Awad MM; Lehtinen MK; Harris MH; Chiarle R
Nat Commun; 2024 Jun; 15(1):5110. PubMed ID: 38877018
[TBL] [Abstract][Full Text] [Related]
31. Non-muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphoma.
Lamant L; Gascoyne RD; Duplantier MM; Armstrong F; Raghab A; Chhanabhai M; Rajcan-Separovic E; Raghab J; Delsol G; Espinos E
Genes Chromosomes Cancer; 2003 Aug; 37(4):427-32. PubMed ID: 12800156
[TBL] [Abstract][Full Text] [Related]
32. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.
Macdonald D; Reiter A; Cross NC
Acta Haematol; 2002; 107(2):101-7. PubMed ID: 11919391
[TBL] [Abstract][Full Text] [Related]
33. FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice.
Guasch G; Delaval B; Arnoulet C; Xie MJ; Xerri L; Sainty D; Birnbaum D; Pébusque MJ
Blood; 2004 Jan; 103(1):309-12. PubMed ID: 12969958
[TBL] [Abstract][Full Text] [Related]
34. Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases.
Chen MK; Hung MC
FEBS J; 2015 Oct; 282(19):3693-721. PubMed ID: 26096795
[TBL] [Abstract][Full Text] [Related]
35. Role of receptor tyrosine kinases mediated signal transduction pathways in tumor growth and angiogenesis-New insight and futuristic vision.
Huang XL; Khan MI; Wang J; Ali R; Ali SW; Zahra QU; Kazmi A; Lolai A; Huang YL; Hussain A; Bilal M; Li F; Qiu B
Int J Biol Macromol; 2021 Jun; 180():739-752. PubMed ID: 33737188
[TBL] [Abstract][Full Text] [Related]
36. Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma.
Sie M; den Dunnen WF; Lourens HJ; Meeuwsen-de Boer TG; Scherpen FJ; Zomerman WW; Kampen KR; Hoving EW; de Bont ES
PLoS One; 2015; 10(3):e0122555. PubMed ID: 25799134
[TBL] [Abstract][Full Text] [Related]
37. Flavonoids as RTK inhibitors and potential anticancer agents.
Teillet F; Boumendjel A; Boutonnat J; Ronot X
Med Res Rev; 2008 Sep; 28(5):715-45. PubMed ID: 18080331
[TBL] [Abstract][Full Text] [Related]
38. A Functional Genetic Screen Identifies the Phosphoinositide 3-kinase Pathway as a Determinant of Resistance to Fibroblast Growth Factor Receptor Inhibitors in FGFR Mutant Urothelial Cell Carcinoma.
Wang L; Šuštić T; Leite de Oliveira R; Lieftink C; Halonen P; van de Ven M; Beijersbergen RL; van den Heuvel MM; Bernards R; van der Heijden MS
Eur Urol; 2017 Jun; 71(6):858-862. PubMed ID: 28108151
[TBL] [Abstract][Full Text] [Related]
39. Regulators of endocytosis maintain localized receptor tyrosine kinase signaling in guided migration.
Jékely G; Sung HH; Luque CM; Rørth P
Dev Cell; 2005 Aug; 9(2):197-207. PubMed ID: 16054027
[TBL] [Abstract][Full Text] [Related]
40. Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation.
Hwang JH; Kim DW; Suh JM; Kim H; Song JH; Hwang ES; Park KC; Chung HK; Kim JM; Lee TH; Yu DY; Shong M
Mol Endocrinol; 2003 Jun; 17(6):1155-66. PubMed ID: 12637586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
